Ultragenyx Pharmaceutical reported $169.75M in Operating Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 158.93M 14.4M
Acceleron Pharma XLRN:US $ 91.6M 3.24M
Agios Pharmaceuticals AGIO:US $ 89.22M 2M
Alexion Pharmaceuticals ALXN:US $ 1000.3M 30.6M
Alnylam Pharmaceuticals ALNY:US $ 366.71M 2.89M
Aptinyx Inc APTX:US $ 19.87M 4.58M
Biocryst Pharmaceuticals BCRX:US $ 79.54M 9.1M
Biomarin Pharmaceutical BMRN:US $ 490.02M 29.08M
Bluebird Bio BLUE:US $ 248.31M 4.31M
Epizyme EPZM:US $ 71.24M 727K
Esperion Therapeutics ESPR:US $ 73.19M 17.61M
Gw Pharmaceuticals GWPH:US 173.49M 2.46M
Insmed INSM:US $ 151.62M 27.57M
IONIS PHARMACEUT IONS:US $ 207.35M 3.77M
Karyopharm Therapeutics KPTI:US $ 71.65M 3.98M
Kyowa Hakko Kirin 4151:JP 69.22B 3.66B
Macrogenics MGNX:US $ 71.04M 2.86M
Mirati Therapeutics MRTX:US $ 164.19M 31.76M
Moderna Inc MRNA:US 1.29B 621M
Neurocrine Biosciences NBIX:US $ 226.1M 21M
Ptc Therapeutics PTCT:US $ 215.17M 921K
Puma Biotechnology PBYI:US $ 55.11M 23.09M
Regeneron Pharmaceuticals REGN:US $ 1791.3M 375.3M
Sarepta Therapeutics SRPT:US $ 331.66M 32.87M
Ultragenyx Pharmaceutical RARE:US $ 169.75M 36.21M
Vertex Pharmaceuticals VRTX:US $ 1831.33M 994.85M
Vital Therapies VTL:US $ 19.17M 13.22M
Xoma XOMA:US $ 4.26M 2.54M